首页> 外文期刊>The Lancet >Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
【24h】

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial

机译:回收扩张心肌病(TRED-HF)患者心力衰竭的药理治疗:开放标签,试验,随机试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background Patients with dilated cardiomyopathy whose symptoms and cardiac function have recovered often ask whether their medications can be stopped. The safety of withdrawing treatment in this situation is unknown.
机译:背景患者患有扩张的心肌病,其症状和心脏功能恢复通常会询问它们的药物是否可以停止。 在这种情况下撤回治疗的安全性是未知的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号